Based on our Pharmacor advisory service entitled Alzheimer’s Disease, Decision Resources is offering an exclusive analyst call entitled Assessing the Impact of Dimebon’s Clinical Trial Failure on the Alzheimer’s Disease Drug Market. Because this presentation features major updates, it is ONLY available to purchasers of this Pharmacor advisory service.

 

This analyst call was held on March 18, 2010. Contact us to learn how you can purchase this Pharmacor advisory service and access a recorded playback of this event.

Click here to view the invite.